Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

There’s been talk about liquid biopsies and the promise of using blood samples to test for a wide variety of cancers at once.

A U.S. official focusing on arms control has provided what he called new, declassified details of a Chinese underground ...

Discord cut ties with its age-verification partner after exposed code fueled federal-reporting concerns, months after a ...

We're relaunching PerfAgents with a renewed focus on performance test orchestration-bringing load testing, real user ...

(HealthDay News) — A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, called Galleri, failed to lower the number ...

GENEVA — A U.S. official focusing on arms control on Monday provided what he called new, declassified details of a Chinese underground nuclear test nearly six years ago and urged countries to press ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...